CrowdStrike falls 9% on disappointing earnings forecast

Ad

Somaderm


In this article

  • CRWD

Follow your favorite stocksCREATE FREE ACCOUNTGeorge Kurtz, co-founder and CEO of CrowdStrike Holdings Inc., during a Bloomberg Technology television interview at the RSA Conference in San Francisco on April 26, 2023.David Paul Morris | Bloomberg | Getty Images

CrowdStrike shares dropped nearly 9% in extended trading on Tuesday after the cybersecurity software provider issued disappointing earnings guidance.

Here’s what the company reported compared to LSEG estimates:

  • Earnings per share: $1.03. The number doesn’t to appear to be comparable to analysts’ estimates.
  • Revenue: $1.06 billion vs. $1.03 billion

Revenue increased 25% from $845.3 million a year earlier, and the company posted a net loss of $92.3 billion, or 37 cents per share. In the year-ago period, the company posted net income of $53.7 million, or 22 cents per share.

For the year, CrowdStrike said it expects earnings, excluding some items, to range between $3.33 and $3.45 per share, falling short of the $4.42 expected by analysts polled by LSEG. First-quarter earnings are expected to be between 64 cents and 66 cents per share, versus the average estimate of 95 cents.

Despite the after-hours drop, CrowdStrike topped some metrics from Wall Street. The company posted $4.24 billion in annual recurring revenue, reflecting 23% growth. That topped the $4.21 billion estimate from analysts surveyed by StreetAccount and included $224 million in net annual recurring revenue.

Revenue guidance was roughly in line with estimates. CrowdStrike said it expects revenue of between $4.74 billion and $4.81 billion for the year, versus an LSEG estimate of $4.77 billion.

The earnings release comes almost eight months after a technology update from the company led to a global IT outage that grounded flights, disrupted businesses and led to class action lawsuits.

CEO George Kurtz said in the press release that artificial intelligence is becoming more important in stopping cyberattacks.

“As businesses of all sizes rapidly adopt AI, stopping the breach necessitates cybersecurity’s AI-native platform,” Kurtz said.

Don’t miss these insights from CNBC PRO

  • Why Tesla’s stock is unraveling and what happens next, according to Barclays
  • How to produce income from Nvidia while waiting for a rebound
  • Hedge funds are buying more of these ‘rising star’ stocks, according to Goldman
  • These S&P 500 stocks are deeply oversold and may be due for a rebound

WATCH: U.S. facing domestic and cyber attacks


Ad

Somaderm

SomaDerm, SomaDerm CBD, SomaDerm AWE (by New U Life).

Somaderm Gel is an advanced scientific formulation created to support your body’s natural growth hormone production. Somaderm is based on the latest research and technology in the field of nutritional supplements and is designed to help you feel and look your best.